NPI: 1629015698 · BECKLEY, WV 25801 · General Acute Care Hospital · NPI assigned 05/31/2006
Authorized official LAWRENCE, CHARLOTTE controls 20+ related entities in our dataset. Read more
| Authorized Official | LAWRENCE, CHARLOTTE (SECRETARY) |
| NPI Enumeration Date | 05/31/2006 |
Other providers sharing the same authorized official: LAWRENCE, CHARLOTTE
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 121,540 | $11.38M |
| 2019 | 86,571 | $6.27M |
| 2020 | 137,775 | $8.93M |
| 2021 | 116,353 | $3.34M |
| 2022 | 72,965 | $2.10M |
| 2023 | 85,958 | $2.58M |
| 2024 | 61,064 | $1.83M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 15,967 | 13,558 | $5.48M |
| 99284 | Emergency department visit for the evaluation and management, high severity | 32,939 | 28,924 | $4.53M |
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 26,148 | 23,671 | $2.22M |
| 93458 | 1,004 | 849 | $1.28M | |
| 36415 | Collection of venous blood by venipuncture | 59,030 | 43,505 | $1.13M |
| 85027 | 59,822 | 45,149 | $1.13M | |
| G0378 | Hospital observation service, per hour | 6,391 | 3,882 | $1.09M |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | 1,687 | 1,479 | $907K |
| 80053 | Comprehensive metabolic panel | 44,375 | 35,839 | $808K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 4,584 | 4,108 | $672K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 27,679 | 22,907 | $652K |
| 80048 | Basic metabolic panel (calcium, ionized) | 12,974 | 9,990 | $522K |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | 5,690 | 5,028 | $449K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 1,719 | 1,567 | $445K |
| 71046 | Radiologic examination, chest; 2 views | 13,349 | 11,929 | $429K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 4,600 | 4,053 | $400K |
| J7120 | Ringers lactate infusion, up to 1000 cc | 2,128 | 1,474 | $392K |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | 4,638 | 2,677 | $391K |
| C1713 | Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) | 147 | 114 | $386K |
| 70450 | Computed tomography, head or brain; without contrast material | 7,143 | 6,339 | $379K |
| 47562 | 98 | 79 | $370K | |
| 84702 | 8,378 | 7,002 | $364K | |
| J7030 | Infusion, normal saline solution , 1000 cc | 7,064 | 4,817 | $349K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 7,023 | 6,320 | $307K |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | 1,821 | 1,591 | $293K |
| J2785 | Injection, regadenoson, 0.1 mg | 1,416 | 1,233 | $293K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 2,435 | 2,105 | $286K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 10,061 | 8,716 | $286K |
| 84484 | 19,620 | 14,257 | $283K | |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 4,608 | 4,299 | $266K |
| 85610 | 13,368 | 11,208 | $265K | |
| C1894 | Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser | 1,254 | 1,039 | $257K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 4,944 | 4,082 | $252K |
| C1769 | Guide wire | 2,316 | 1,871 | $247K |
| 71045 | Radiologic examination, chest; single view | 12,646 | 10,871 | $231K |
| 81003 | 22,124 | 19,284 | $223K | |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 2,369 | 2,153 | $223K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 9,823 | 8,755 | $215K |
| 93017 | 1,800 | 1,573 | $207K | |
| 71275 | Computed tomographic angiography, chest, with contrast material | 1,104 | 984 | $203K |
| 87086 | Culture, bacterial; quantitative colony count, urine | 9,060 | 7,984 | $203K |
| 41899 | Unlisted procedure, dentoalveolar structures | 346 | 307 | $201K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 4,068 | 2,813 | $193K |
| 85730 | 10,767 | 9,273 | $191K | |
| 99152 | 1,063 | 887 | $169K | |
| 84703 | 2,181 | 1,926 | $160K | |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 601 | 545 | $154K |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | 1,176 | 1,118 | $150K |
| 83690 | 16,774 | 14,419 | $144K | |
| 78815 | Positron emission tomography (PET) for limited area imaging | 447 | 406 | $136K |
| C9600 | Percutaneous transcatheter placement of drug eluting intracoronary stent(s), with coronary angioplasty when performed; single major coronary artery or branch | 46 | 41 | $130K |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | 658 | 599 | $125K |
| 86850 | 2,358 | 1,970 | $122K | |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | 350 | 324 | $114K |
| 87186 | 5,412 | 4,422 | $114K | |
| 87077 | 5,022 | 4,380 | $108K | |
| C1887 | Catheter, guiding (may include infusion/perfusion capability) | 801 | 665 | $107K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 9,473 | 8,195 | $107K |
| 96361 | Intravenous infusion, hydration; each additional hour | 2,559 | 2,140 | $103K |
| 76000 | 956 | 776 | $103K | |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | 341 | 317 | $100K |
| A9552 | Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 404 | 369 | $100K |
| 96375 | Therapeutic injection; each additional sequential IV push | 5,137 | 4,315 | $96K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 1,356 | 1,079 | $91K |
| 83880 | 3,582 | 3,100 | $86K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | 1,404 | 1,260 | $85K |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | 1,318 | 1,261 | $84K |
| 88304 | 374 | 320 | $84K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 2,242 | 1,962 | $83K |
| 72125 | Computed tomography, cervical spine; without contrast material | 1,600 | 1,438 | $81K |
| 71250 | 1,352 | 1,268 | $80K | |
| 84443 | Thyroid stimulating hormone (TSH) | 5,229 | 4,677 | $78K |
| 83605 | 7,030 | 5,875 | $78K | |
| 84145 | 3,383 | 2,951 | $74K | |
| 87040 | 5,010 | 3,332 | $72K | |
| 87070 | 2,389 | 2,051 | $71K | |
| 93971 | 1,020 | 924 | $70K | |
| 73630 | 2,473 | 2,015 | $70K | |
| 85379 | 2,712 | 2,366 | $69K | |
| 73562 | 2,495 | 1,987 | $68K | |
| 83735 | 6,603 | 4,828 | $68K | |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | 383 | 349 | $67K |
| 73030 | 2,465 | 2,083 | $66K | |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | 423 | 382 | $66K |
| A9585 | Injection, gadobutrol, 0.1 ml | 574 | 530 | $66K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 2,304 | 1,684 | $64K |
| 70551 | Magnetic resonance imaging, brain; without contrast material | 490 | 456 | $63K |
| 87205 | 2,337 | 1,957 | $62K | |
| 80061 | Lipid panel | 3,492 | 3,091 | $62K |
| 73610 | 1,887 | 1,580 | $60K | |
| 72141 | 310 | 295 | $57K | |
| 87400 | 2,384 | 1,706 | $55K | |
| 59025 | Fetal non-stress test | 1,022 | 753 | $51K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 1,608 | 1,290 | $49K |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | 752 | 622 | $49K |
| 88307 | 213 | 172 | $48K | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 559 | 494 | $46K |
| J1644 | Injection, heparin sodium, per 1000 units | 1,013 | 842 | $46K |
| 74018 | 1,772 | 1,616 | $42K | |
| 72100 | 1,308 | 1,195 | $42K | |
| 80074 | 716 | 631 | $40K | |
| 73130 | 1,238 | 1,040 | $40K | |
| 82805 | 609 | 489 | $40K | |
| 76770 | 631 | 577 | $39K | |
| 70498 | 219 | 194 | $39K | |
| 99153 | Mod sedat endo service >5yrs | 252 | 218 | $36K |
| 82550 | 2,208 | 1,452 | $36K | |
| 82553 | 1,415 | 851 | $36K | |
| 72110 | 973 | 906 | $35K | |
| 78227 | 142 | 140 | $34K | |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 2,658 | 1,901 | $32K |
| 70496 | 104 | 86 | $31K | |
| 72131 | 451 | 405 | $31K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 1,768 | 1,643 | $30K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | 1,307 | 716 | $29K |
| 45378 | Colonoscopy, flexible; diagnostic, including collection of specimen(s) | 83 | 79 | $29K |
| A9537 | Technetium tc-99m mebrofenin, diagnostic, per study dose, up to 15 millicuries | 242 | 211 | $29K |
| A9270 | Non-covered item or service | 890 | 437 | $29K |
| 94060 | 621 | 587 | $28K | |
| 73110 | 1,066 | 864 | $28K | |
| 99218 | 415 | 291 | $27K | |
| 94729 | 609 | 574 | $27K | |
| 94726 | 618 | 583 | $27K | |
| 83036 | Hemoglobin; glycosylated (A1C) | 2,584 | 2,311 | $26K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 1,016 | 950 | $26K |
| 73502 | 1,586 | 1,448 | $25K | |
| 90715 | 277 | 254 | $25K | |
| 10060 | 158 | 133 | $24K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 1,977 | 1,736 | $24K |
| 93880 | 184 | 171 | $23K | |
| 72114 | 737 | 700 | $23K | |
| 72072 | 686 | 636 | $22K | |
| 74019 | 682 | 623 | $22K | |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | 317 | 258 | $22K |
| 73590 | 714 | 594 | $20K | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 609 | 552 | $20K |
| 87581 | 604 | 548 | $20K | |
| 87486 | 603 | 547 | $20K | |
| 73564 | 649 | 481 | $19K | |
| 85652 | 982 | 831 | $19K | |
| 70486 | 158 | 142 | $18K | |
| J2704 | Injection, propofol, 10 mg | 179 | 159 | $18K |
| 85347 | 255 | 165 | $17K | |
| 86140 | 1,339 | 1,102 | $16K | |
| 72050 | 351 | 325 | $16K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 458 | 420 | $16K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 458 | 420 | $16K |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | 841 | 785 | $16K |
| 84439 | 859 | 788 | $15K | |
| 93970 | 160 | 144 | $15K | |
| 84112 | 120 | 103 | $13K | |
| P9016 | Red blood cells, leukocytes reduced, each unit | 51 | 41 | $13K |
| 73090 | 426 | 350 | $13K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 558 | 524 | $13K |
| 87420 | 390 | 352 | $13K | |
| 76830 | Ultrasound, transvaginal | 213 | 190 | $13K |
| 80069 | 698 | 471 | $11K | |
| J1610 | Injection, glucagon hydrochloride, per 1 mg | 17 | 14 | $11K |
| 82607 | 570 | 528 | $11K | |
| 73080 | 333 | 286 | $10K | |
| 12001 | 102 | 95 | $10K | |
| 78264 | 15 | 14 | $10K | |
| 87522 | Neg quan hep c or qual rna | 192 | 180 | $10K |
| 87081 | 424 | 398 | $9K | |
| 96376 | 300 | 251 | $9K | |
| 82248 | 473 | 399 | $8K | |
| 72128 | 42 | 37 | $8K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 381 | 347 | $8K |
| 74178 | 50 | 49 | $8K | |
| 82565 | 232 | 201 | $8K | |
| 82150 | 405 | 341 | $8K | |
| 29125 | 67 | 64 | $8K | |
| 91200 | 335 | 312 | $8K | |
| 80076 | 293 | 263 | $8K | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | 117 | 105 | $7K |
| 86689 | 233 | 205 | $7K | |
| J2805 | Injection, sincalide, 5 micrograms | 67 | 67 | $7K |
| 73552 | 484 | 408 | $7K | |
| J0561 | Injection, penicillin g benzathine, 100,000 units | 42 | 35 | $6K |
| 86900 | 251 | 224 | $6K | |
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 280 | 255 | $5K |
| 97162 | 77 | 56 | $5K | |
| 84436 | 439 | 410 | $5K | |
| 83540 | 696 | 639 | $5K | |
| 76536 | 97 | 95 | $5K | |
| 86922 | 115 | 87 | $5K | |
| 86901 | 251 | 224 | $5K | |
| 82570 | 501 | 383 | $5K | |
| 72040 | 222 | 196 | $4K | |
| 88108 | 167 | 154 | $4K | |
| 36430 | 53 | 40 | $4K | |
| 84550 | 262 | 212 | $4K | |
| 12002 | 48 | 43 | $4K | |
| 84520 | 96 | 82 | $4K | |
| 87507 | 15 | 14 | $4K | |
| 82247 | 382 | 298 | $3K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 56 | 43 | $3K |
| 29515 | 25 | 24 | $3K | |
| 82977 | 217 | 192 | $3K | |
| 82274 | 149 | 141 | $3K | |
| 73221 | 44 | 44 | $3K | |
| 84156 | 346 | 217 | $3K | |
| A6209 | Foam dressing, wound cover, sterile, pad size 16 sq. in. or less, without adhesive border, each dressing | 2,202 | 1,252 | $3K |
| 81001 | 1,766 | 1,417 | $3K | |
| 82746 | 92 | 86 | $3K | |
| 95816 | 17 | 14 | $3K | |
| 74022 | 33 | 31 | $3K | |
| 51702 | 93 | 80 | $2K | |
| 86038 | 14 | 12 | $2K | |
| 12011 | 14 | 13 | $2K | |
| 88342 | 63 | 58 | $2K | |
| 78306 | 26 | 26 | $2K | |
| 11043 | 15 | 12 | $2K | |
| 72170 | 50 | 48 | $2K | |
| A9503 | Technetium tc-99m medronate, diagnostic, per study dose, up to 30 millicuries | 28 | 28 | $2K |
| A9541 | Technetium tc-99m sulfur colloid, diagnostic, per study dose, up to 20 millicuries | 15 | 14 | $2K |
| G0297 | Low dose ct scan (ldct) for lung cancer screening | 15 | 12 | $2K |
| 99204 | Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 97 | 92 | $2K |
| 76870 | 15 | 13 | $2K | |
| 84460 | 82 | 73 | $1K | |
| 73560 | 104 | 83 | $1K | |
| 93307 | 57 | 44 | $1K | |
| 82728 | 131 | 120 | $1K | |
| C1758 | Catheter, ureteral | 47 | 37 | $1K |
| 73521 | 47 | 42 | $1K | |
| 99215 | Prolong outpt/office vis | 14 | 12 | $1K |
| A9576 | Injection, gadoteridol, (prohance multipack), per ml | 188 | 176 | $1K |
| 83010 | 98 | 96 | $1K | |
| 87088 | 44 | 39 | $1K | |
| 86706 | 54 | 50 | $1K | |
| 43235 | 13 | 13 | $1K | |
| 73600 | 16 | 13 | $1K | |
| 82948 | 601 | 422 | $940.75 | |
| 83550 | 131 | 119 | $924.53 | |
| 83516 | 36 | 28 | $880.75 | |
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 44 | 39 | $863.65 |
| 58552 | 13 | 12 | $834.13 | |
| 82140 | 78 | 64 | $795.94 | |
| 74220 | 12 | 12 | $754.28 | |
| 83883 | 62 | 61 | $738.15 | |
| 82172 | 50 | 49 | $667.71 | |
| 82784 | 69 | 62 | $663.40 | |
| 84100 | 73 | 67 | $623.44 | |
| 97597 | 72 | 53 | $612.97 | |
| 83655 | 44 | 41 | $509.92 | |
| 84479 | 30 | 27 | $506.51 | |
| 72052 | 28 | 25 | $463.66 | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 120 | 114 | $424.86 |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 21 | 12 | $406.43 |
| 76819 | Fetal biophysical profile; without non-stress testing | 18 | 13 | $378.72 |
| 87340 | 25 | 24 | $336.99 | |
| 86803 | 12 | 12 | $268.62 | |
| 82009 | 49 | 41 | $223.04 | |
| 82103 | 12 | 12 | $213.88 | |
| 71271 | 16 | 14 | $213.48 | |
| 71101 | 13 | 12 | $181.15 | |
| 73060 | 14 | 12 | $149.46 | |
| 85014 | 53 | 43 | $148.47 | |
| 85018 | 33 | 27 | $144.19 | |
| 84481 | 12 | 12 | $141.02 | |
| 84478 | 36 | 36 | $132.70 | |
| J1956 | Injection, levofloxacin, 250 mg | 24 | 14 | $122.24 |
| 82465 | 36 | 36 | $100.62 | |
| 87102 | 15 | 13 | $83.73 | |
| 87206 | 19 | 13 | $82.89 | |
| A6021 | Collagen dressing, sterile, size 16 sq. in. or less, each | 223 | 131 | $67.45 |
| J7050 | Infusion, normal saline solution, 250 cc | 22 | 21 | $8.00 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 113 | 106 | $7.59 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 101 | 83 | $0.44 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 119 | 99 | $0.13 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 96 | 92 | $0.00 |